Small molecule synthesis IDIQ base award for usamriid
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- W81XWH22D0016
- Awardee
-
Creagen Inc. UEI TR7EMJYU1KL9
- Awarding agency
-
Defense Health Agency
Department of Defense
- Task orders
- 2 $105,427 obligated
Award facts
- Opportunity
-
- Small Molecule Synthesis in support of the U. S. Army Medical Research Institute of Infectious Diseases (USAMRIID) Solicitation · W81XWH22R0084 · Posted Aug 8, 2022
- Combined order value
- $105,427 Current and potential, with all options
- Last date to order 82% complete
- IDV ceiling 4% used
- $2,409,960.00
- Maximum order
- $1,204,980.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Defense Health Agency awarded an indefinite-delivery contract to Creagen Inc., an SBA Certified 8(a) Program Participant, with a ceiling of $2,409,960 on September 21, 2022. This is a single-award contract set aside for total small business.
Work is performed in Woburn, Massachusetts. The IDIQ procures synthesis of small molecules to support drug discovery projects at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), including development of novel small molecule inhibitor analogs for infectious disease countermeasure research.
The contract runs through September 25, 2027. Under this IDIQ, Creagen has issued two delivery orders to date: a $37,209.60 firm fixed price order (task order 01) completed May 12, 2023, and a $68,217.60 firm fixed price order (task order 02) completed November 30, 2023, both for small molecule synthesis supporting USAMRIID's infectious disease research program. The ordering activity reflects the Defense Health Agency's engagement of Creagen's synthetic chemistry capabilities for biodefense applications.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Small molecule synthesis task order 02 for usamriid | Defense Health Agency | $68,218 | |
| Small molecule synthesis task order 01 for usamriid | Defense Health Agency | $37,210 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract W81XWH22D0016?
W81XWH22D0016 was awarded to Creagen Inc. by Defense Health Agency (Department of Defense) on September 21, 2022.
How much is contract W81XWH22D0016 worth?
Orders under W81XWH22D0016 have obligated $105,427. W81XWH22D0016's own ceiling is $2,409,960. A single order can be worth up to $1,204,980.
How many orders have been placed under contract W81XWH22D0016?
2 orders have been placed under W81XWH22D0016, the latest on June 5, 2023.
Who can order from contract W81XWH22D0016?
W81XWH22D0016 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract W81XWH22D0016 competed?
The extent of competition for W81XWH22D0016 was competed under sap. The government received 3 offers. It was set aside: Total Small Business.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV